NovelStem International Corp.: Form 10-Q for the period ended Jun 30, 2013
Filed with the SEC on Aug 14, 2013 and accepted by EDGAR at Aug 14, 2013, 07:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-04-01 to 2013-06-30 | $102.4k | us-gaap:SalesRevenueNet |
| Revenue | 6 months2013-01-01 to 2013-06-30 | $183.5k | us-gaap:SalesRevenueNet |
| Selling, general and administrative | 3 months2013-04-01 to 2013-06-30 | $755.1k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2013-01-01 to 2013-06-30 | $1.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2013-04-01 to 2013-06-30 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2013-01-01 to 2013-06-30 | −$2.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2013-04-01 to 2013-06-30 | $17.9k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2013-01-01 to 2013-06-30 | $40.8k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-04-01 to 2013-06-30 | −$43.0k | us-gaap:ProfitLoss |
| Net income | 6 months2013-01-01 to 2013-06-30 | −$331.7k | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2013-04-01 to 2013-06-30 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2013-01-01 to 2013-06-30 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months2013-04-01 to 2013-06-30 | 22,648,740 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2013-01-01 to 2013-06-30 | 22,712,110 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2013-01-01 to 2013-06-30 | −$2.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2013-04-01 to 2013-06-30 | $6.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2013-01-01 to 2013-06-30 | $47.2k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2013-04-01 to 2013-06-30 | $16.1k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 6 months2013-01-01 to 2013-06-30 | $766.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2013-06-30 | $9.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-06-30 | $13.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-06-30 | $25.6m | us-gaap:Assets |
| Current liabilities | At period end2013-06-30 | $1.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-06-30 | $1.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-06-30 | $23.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-13-045387. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.